Mobile classification in microarray experiments

Scandinavian Journal of Immunology, Supplement

Volumn 62, Issue 1, 2005, Pages 84-91

  Dozmorov, I M ^a   Centola, M ^a   Knowlton, N ^a   Tang, Y ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROHN DISEASE; DNA MICROARRAY; ENTERITIS; GENE EXPRESSION; GENETIC VARIABILITY; MATHEMATICAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 23744470449     PISSN: 03016323     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01614.x     Document Type: Article

References (35)

1. Jarvis JN, Dozmorov I, Jiang K et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2004;6:R15-32.
2. Dozmorov I, Knowlton N, Tang Y et al. Hypervariable genes - experimental error or hidden dynamics. Nucleic Acids Res 2004;32:147.
3. Dozmorov I, Centola M. An associative analysis of gene expression array data. Bioinformatics 2003;19:204-11.
4. Knowlton N, Dozmorov IM, Centola M. Microarray data analysis toolbox (MDAT): for normalization, adjustment and analysis of gene expression data. Bioinformatics 2004;20:3687-90.
5. Dozmorov I, Knowlton N, Tang Y, Centola M. Statistical monitoring of weak spots for improvement of normalization and ratio estimates in microarrays. BMC Bioinformatics 2004;5:53.
6. Dozmorov I, Saban MR, Knowlton N, Centola M, Saban R. Connective molecular pathways of experimental bladder inflammation. Physiol Genomics 2003;15:209-22.
7. Jarvis JN, Dozmorov I, Jiang K et al. Gene expression arrays reveal a rapid return to normal homeostasis in immunologically-challenged trophoblast-like JAR cells. J Reprod Immunol 2004;61:99-113.
8. Jorgensen ED, Dozmorov I, Frank MB, Centola M, Albino AP. Global gene expression analysis of human bronchial epithelial cells treated with tobacco condensates. Cell Cycle 2004;3:1154-68.
9. Zimmerman RA, Dozmorov I, Nunlist EH et al. 5a-Androstane-3a,17b-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer lncap cell proliferation. Prostate Cancer Prostatic Dis 2004;7:364-74.
10. Toh H, Horimoto K. Inference of a genetic network by a combined approach of cluster analysis and graphical Gaussian modeling. Bioinformatics 2002;18:287-97.
11. Olsson J, Poles M, Spetz AL et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 2000;182:1625-35.
12. Matussek A, Lauber J, Bergau A et al. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 2003;102:1323-32.
13. Del Zotto B, Mumolo G, Pronio AM, Montesani C, Tersigni R, Boirivant M. TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol 2003;134:120-6
14. (Erratum in: Clin Exp Immunol 2003;134:365).
15. Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Increased expression of IL-16 in inflammatory bowel disease. Gut 2001;48:326-32.
16. Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004;99:938-45.
17. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001;10:445-56.
18. McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001;50:491-5.
19. Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004;126:1771-8.
20. Kirkwood SC, Su JL, Conneally P, Foroud T. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol 2001;58:273-8.
21. Morgan RW, Sofer L, Anderson AS, Bernberg EL, Cui J, Burnside J. Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus. J Virol 2001;75:533-9.
22. Day RM, Mitchell TJ, Knight SC, Forbes A. Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine 2003;21:224-33.
23. Uno T, Ryu D, Tsutsumi H et al. Residues in the distal heme pocket of neuroglobin. Implications for the multiple ligand binding steps. J Biol Chem 2004;279:5886-93.
24. Mutchnick MG, Lee HH, Hollander DI, Haynes GD, Chua DC. Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease. Clin Immunol Immunopathol 1988;47:84-92.
25. Torres MI, Le Discorde M, Lorite P et al. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol 2004;16:579-83.
26. + T cells and proinflammatory Th1-type cytokines. J Immunol 1997;158:1068-77.
27. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Increased expression of antimicrobial peptides and lysozyme in colonie epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 2003;131:90-101.
28. Scott LA, Vass JK, Parkinson EK, Gillespie DA, Winnie JN, Ozanne BW. Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53. Mol Cell Biol 2004;24:1540-59.
29. Pappas P, Sotiropoulou M, Karamanakos P, Kostoula A, Levidiotou S, Marselos M. Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1. Chem Biol Interact 2003;143-144:55-62.
30. Pappas P, Stephanou P, Vasiliou V, Marselos M. Anti-inflammatory agents and inducibility of hepatic drug metabolism. Eur J Drug Metab Pharmacokinet 1998;23:457-60.
31. Saban MR, Nguyen NB, Hammond TG, Saban R. Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 2002;160:2095-110.
32. Adcock IM. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001;14:211-9.
33. de Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003;9:316-20.
34. Aadland E, Fagerhol MK. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:823-5.
35. Petrov RV, Lebedev KA, Poniakina ID, Petrukhin IS. Interrelation of the immunological parameters of healthy donors and of persons frequently ill with acute respiratory diseases and bronchitis in the remission stage (a new approach to assessing immune status). Zh Mikrobiol Epidemiol Immunobiol 1983;9:99-105.